The Mortality Burden of Idiopathic Pulmonary Fibrosis in the United Kingdom-Reference-Cited by-同舟云学术

The Mortality Burden of Idiopathic Pulmonary Fibrosis in the United Kingdom

Published:2019-07-15 Issue:2 Volume:200 Page:256-258
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Navaratnam Vidya¹²^ORCID,Hubbard Richard B.¹

Affiliation:

1. University of NottinghamNottingham, United Kingdomand

2. Menzies School of Health ResearchDarwin, Australia

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201902-0467LE

Reference9 articles.

1. The rising incidence of idiopathic pulmonary fibrosis in the UK

2. Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century

3. Rising mortality from cryptogenic fibrosing alveolitis.

4. Office for National Statistics. Death certification reform: a case study on the potential impact on mortality statistics, England and Wales. Statistical Bulletin; 2012.

5. The Increasing Secondary Care Burden of Idiopathic Pulmonary Fibrosis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A composite score based on cardiovascular parameters can predict the mortality risk of patients with newly diagnosed interstitial lung disease: A prospective observational study;J CARDIOL;2024

2. A composite score based on cardiovascular parameters can predict the mortality risk of patients with newly diagnosed interstitial lung disease: A prospective observational study;Journal of Cardiology;2024-10

3. Mortality trends in idiopathic pulmonary fibrosis in Europe between 2013 and 2018;European Respiratory Journal;2024-06-13

4. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study;Thorax;2024-04-30

5. Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials;Clinical and Translational Medicine;2024-01